Cisplatin treatment (9 mg/kg) causes bloating of the stomach, an increase i
n gastric acid, and ulceration in rats. Gastrin, a gut peptide, plays an im
portant role in regulating gastric acid production. To study the role of ga
strin in this increased gastric acid production after cisplatin treatment,
male Wistar rats (100-150 g) were treated with cisplatin (9 mg/kg) in five
divided doses over 5 consecutive days. The rats were sacrificed 1, 6, 10, o
r 15 days after the last treatment. As measured by immunocytochemistry, in
situ hybridization, Northern blot, and dot-blot techniques, gastrin was fou
nd to be below detectable limits just 1 day after cisplatin treatment. Howe
ver, 10-15 days after the last injection, the levels for both gastrin and i
ts mRNA gradually recovered to normal. Northern blot studies showed that de
creased somatostatin mRNA parallels the changes of gastrin and its mRNA. Th
ese results suggest that after cisplatin treatment the increased gastric ac
id production in rat stomach is independent of gastrin. This decrease of ga
strin production is not under the influence of somatostatin, which also dec
reased after cisplatin treatment.